Experimental device offers glycemic control to hyperinsulinism patients after pancreatectomy

Researchers at Children’s Hospital of Philadelphia have demonstrated that an experimental device can improve blood sugar control in patients who developed diabetes after their pancreas was removed to treat their hyperinsulinism, a genetic disease in which the pancreas produces too much insulin.